HOMECARE SELF-MONITORING DEVICE MARKET ANALYSIS

Homecare Self-Monitoring Device MarketSize and Trends

Global homecare self-monitoring device market is estimated to be valued at US$ 6.06 Billion in 2023 and is expected to exhibit a CAGR of 4.9% during the forecast period (2023-2030). Increasing investment for product launch by the key market players is expected to assist in the growth of the market over the forecast period. For instance, in the year 2022, Roche Diabetes Care part of F. Hoffmann-La Roche AG, is a Europe based multinational healthcare company featured two new blood glucose meter products i.e. “ACCU-CHEK Instant Glucometer” and “ACCU-CHEK Guide Me” Glucometer, which is a new digital diabetes management platform. It also matches all aspects of ISO 15197:2013. Simply the results show on the mySugr app on the patient’s smartphone.

Global Homecare Self-monitoring Device market- Driver

Facility expansion by the market players

Market players are indulged in facility expansion, which is expected to increase the production of self-monitoring devices for blood pressure monitors, which is expected to drive the growth of the Homecare self-monitoring device market over the forecast period. For instance, on September 13, 2022, Philips N.V.’s a Europe based multinational conglomerate corporation, new study validates ambulatory monitoring as a critical component of cardiac care, prescribing Philips MCOT (Mobile Cardiac Outpatient Telemetry) solution may support improved patient outcomes and cost savings by monitoring for arrhythmic disturbances and encouraging timely intervention.